Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerEleni Andreopoulou, Franco M. Muggia, Darci Gaiotti et al.|Annals of Oncology|2007Cited by 83
Safety of prolonged Doxil administration in recurrent gynecologic cancersFranco M. Muggia, Anne Hamilton, E. Kim et al.|Journal of Clinical Oncology|2004Cited by 7
Largest series of extrapulmonary small cell carcinoma (ESCC): The Saskatchewan ExperienceKamal Haider, Shahid Ahmed, D. Mirchandani et al.|Journal of Clinical Oncology|2004Cited by 1
Safety of prolonged Doxil administration in recurrent gynecologic cancersFranco M. Muggia, Anne Hamilton, Howard S. Höchster et al.|Journal of Clinical Oncology|2004Cited by 1